ARCHIVES

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

NCI Plans to Fund FY 1985 R01s, P01s with Cuts 2.9-3.8% Under Recommended Groups, Centers Reduced 7-10%

March 16, 1984

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

NCI, Advisers Lean To Smaller Increases For R01a, Philosophy Of Spreading Money Among More Grants

January 15, 1982

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

House Launches Probe of NCI Spending On Cancer Communications, Education

April 12, 2013